The study, published in the journal JAMA Network Open, found that if the azithromycin drug is taken with certain other drugs that affect the electrical functioning of the heart, then cardiac events increased.
Category: study
BCG vax protects old people from respiratory infections: Study
'Two years ago we started the ACTIVATE study, with the aim of showing whether BCG vaccination could protect against infections in vulnerable elderly people,' said study researcher Mihai Netea from Radboud University in the Netherlands.
Mandatory BCG vaccination linked with slower Covid-19 growth
Adding to the growing evidence that early BCG vaccination may be helpful in taming the Covid-19 spread, scientists now claim that countries with mandatory BCG vaccination until at least the year 2000 tended to exhibit slower infection and death rates during the first 30 days of the outbreak.
COVID-19 may cause deadly blood clots in pregnant women
In a fight against the novel coronavirus, researchers have revealed that COVID-19 may increase the risk of blot clots in women who are pregnant or taking estrogen with birth control or hormone replacement therapy.
Depression, stress higher during peak of Covid-19 pandemic
Australian researchers have found that rates of elevated psychological distress, including depression and anxiety symptoms, were found among adults during the peak of the Covid-19 outbreak.
Researchers identify possible drug target for prostate cancer
Researchers have long studied a family of three closely-related proteins, called BET bromodomain proteins, composed of BRD2, BRD3 and BRD4, which regulate gene expression.
Respiratory droplets from cough last longer in humid, cold climates
Their model is the first to be based on a fundamental approach taken to study chemical reactions called collision rate theory, which looks at the interaction and collision rates of a droplet cloud exhaled by an infected person with healthy people.
New nano drug candidate kills aggressive breast cancer cells
The research team linked a new class of nanomaterials, called metal-organic frameworks, with the ligands of an already-developed photodynamic therapy drug to create a nanoporous material that targets and kills tumour cells without creating toxicity for normal cells.
Researchers develop coating that kills corona virus in 1 hour
The researchers have developed a surface coating, which, when painted on common objects like doorknobs or light switches, can inactivate SARS-CoV-2 in one hour, the virus that causes COVID-19.
Major study finds fatty acid that kills cancer cells
Results found in the C. elegans cells are also often transferable to human cells. The research team discovered that feeding nematodes a diet of DGLA-laden bacteria killed all the germ cells in the worms as well as the stem cells that make the germ cells.
Drug Umifenovir secures nod for clinical trial for Covid-19
Amid the race to find a cure for the deadly coronavirus infection, Council of Scientific and Industrial Research (CSIR)-constituent lab CSIR-Central Drug Research Institute (CDRI) in Lucknow has received permission to carry out Phase III trial of antiviral drug Umifenovir.
Cheap steroid drug may save serious Covid patients: British researchers
British experts say the low-dose steroid -- which costs around five pounds -- is a major breakthrough in the fight against the deadly virus, cutting the risk of death by a third for patients on ventilators, the BBC reported.
Covid-19 may actually trigger diabetes in healthy people: Study
In a significant find, a new study has said that the novel coronavirus behind Covid-19 may actually trigger onset of diabetes in healthy people, apart from causing severe complications of pre-existing diabetes.
Johnson & Johnson to begin human trial of Covid vaccine in July
Johnson & Johnson on Wednesday said that it has accelerated the first in-human clinical trial of its investigational SARS-CoV-2 vaccine in the second half of July via its Janssen Pharmaceutical Companies (Janssen).
Early Covid-19 test produces 'false negative' results: Johns Hopkins study
Researchers at the US' Johns Hopkins University have found that testing people for Covid-19 too early is likely to produce "false negative" results, even though they may eventually test positive for the virus.
Experts predict COVID-19 vaccine may take 12-18 months: Report
Scientists still predict a safe and effective vaccine against SARS-CoV-2, the virus that causes COVID-19 could take at least 12-18 months to develop, according to a new report from the New York Times.
Smokers more vulnerable to Covid-19, say experts
According to a University College London study, smokers are 1.45 times more likely to have severe complications compared with non-smokers and those who quit smoking.
'Historic commitments' at Global Vaccine Summit
The virtual Global Vaccine Summit hosted by the UK drew pledges of $8.8 billion, far more than its target of $7.4 billion, showing 'historic commitments' made by world leaders to provide equal access to vaccines for all.
AstraZeneca joins Serum Institute to supply 1bn doses of Oxford vaccine
Adar Poonawalla, Chief Executive Officer, SII, said that the Serum Institute of India is delighted to partner with AstraZeneca in bringing this vaccine to India as well as low-and-middle-income countries.
Plasma therapy safe, effective for severe Covid-19 patients: Study
Results of the trial showed that 19 out of 25 patients (76 per cent) improved with the treatment and 11 were discharged from the hospital. There were no serious adverse side effects caused by the plasma transfusion.
NRI scientist develops test that visually detects coronavirus in 10 mins
A team of US scientists led by an Indian-origin researcher has developed an experimental diagnostic test for COVID-19 that can visually detect the presence of coronavirus in 10 minutes.
Covid-19 vaccine could be ready by October, claims Pfizer CEO
Pfizer is conducting clinical trials in the US and Europe for the BNT162 vaccine programme to prevent Covid-19 in collaboration with German mRNA company BioNTech.
'Human trials for COVID-19 vaccine may begin in at least 6 months'
As India ranked 10th in the global infection list, overtaking Iran, which was an early hotspot of coronavirus, India's top medical body has said the human trials of COVID-19 vaccine may begin at least in six months.
50% chance Oxford Covid-19 vaccine trial will yield 'no result'
Due to a decline in infection rate, the team at Oxford University developing a Covid-19 vaccine believe that the chances of the trial yielding "no result" is now 50 per cent, The Telegraph reported.
Lungs of dead COVID-19 patients show distinctive features: Study
They compared this group to seven autopsied lungs obtained from patients who died of acute respiratory distress syndrome secondary to influenza A (H1N1) infection as well as to 10 age-matched uninfected control lungs.